FGFR Pathway Inhibition in Gastric Cancer: The Golden Era of an Old Target?

Gastric cancer (GC) is the third leading cause of cancer-associated death worldwide. The majority of patients are diagnosed at an advanced/metastatic stage of disease due to a lack of specific symptoms and lack of screening programs, especially in Western countries. Thus, despite the improvement in...

Descripción completa

Detalles Bibliográficos
Autores principales: Lengyel, Csongor G., Hussain, Sadaqat, Seeber, Andreas, Jamil Nidhamalddin, Sara, Trapani, Dario, Habeeb, Baker S., Elfaham, Essam, Mazher, Syed Ayub, Seid, Fahmi, Khan, Shah Z., El Bairi, Khalid, Odhiambo, Andrew, Altuna, Sara C., Petrillo, Angelica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778800/
https://www.ncbi.nlm.nih.gov/pubmed/35054474
http://dx.doi.org/10.3390/life12010081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778800/
https://www.ncbi.nlm.nih.gov/pubmed/35054474
http://dx.doi.org/10.3390/life12010081

Ejemplares similares